Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.
about
Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancerBinding of human and rat CD59 to the terminal complement complexesMatrix-assisted laser desorption/ionization mass spectrometry of carbohydrates.Structural study on the carbohydrate moiety of calf intestinal alkaline phosphatase.Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59).A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases.Down-regulation of glycosylphosphatidylinositol-specific phospholipase D induced by lipopolysaccharide and oxidative stress in the murine monocyte- macrophage cell line RAW 264.7.Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE.On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni.Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.Role of complement and complement regulatory proteins in the complications of diabetesMolecular basis for a link between complement and the vascular complications of diabetesA new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patientThe novel diagnostic biomarkers for focal segmental glomerulosclerosis.Complement in cancer and cancer immunotherapy.The GPI-anchoring of PrP: implications in sorting and pathogenesis.Capacitation-Associated Glycocomponents of Mammalian Sperm.Complement-regulatory proteins in ovarian malignancies.Efficient glycosylphosphatidylinositol (GPI) modification of membrane proteins requires a C-terminal anchoring signal of marginal hydrophobicitySoluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation.Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers.Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy.Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells.The Glycosylation of the Complement Regulatory Protein, Human Erythrocyte CD59
P2860
Q24673693-5CF21B2E-B1FE-40B6-B9A8-4E233C0F053CQ28565870-9DA5633A-2B8F-4944-BDE8-F7937DB5B8FFQ30833304-75C54BA7-E75A-4186-B94B-D0299EE67BF1Q31004769-E7136572-4B05-4FE6-8114-1EDC8D4E4DD7Q33753497-7EB9ABF0-6529-4A5E-B368-0EA19DA9BA0CQ33952821-37E5E60B-A265-4029-B1F9-A77B74B7BD8AQ34007338-CF6B9FE5-BE15-4FBD-BCC4-C26CE0C39C88Q34069606-CABDE929-DD83-4710-AB4F-5146030B06CFQ35037028-F41F6D8B-24DB-4F3D-83B8-1F5ECF86001DQ35095565-754254EB-A585-4BDE-B3F3-334B177F082FQ35657115-4ECF31E4-7D1A-4A31-90F5-FDDF22947B55Q36977373-EB0DE850-8135-444A-B0E3-3AF2BBF435F9Q37652769-75EF0124-CF7F-4EB1-8C53-A6F4DB29B6E7Q37699843-3762E78C-F442-4C4A-968F-13D24220559DQ37940918-D1ED8FA2-F38A-4E89-9A08-DC718F96B2EFQ38186552-1D334251-4C14-448D-8CDF-301399951CB2Q38585448-C8E67FD9-F87F-47D0-BB39-551E87C11CB1Q41135107-8F149A33-179F-4C59-927E-6C538F55A0E3Q41766630-BF98DD02-4D8A-4089-A606-23ABD1CC3F0AQ42767292-EEE8EF06-36EE-4FE3-93D4-ECBDE05A91EDQ46080553-545C8E09-D9C1-44BB-8367-9ECFE8F7CE8DQ51809953-DCC4C6EF-4B2F-47A8-BABC-C881A0DD6C97Q52942551-15AE47CB-CC2C-4CBA-8FE7-F86A273B8EAAQ53981715-1D8BF0B8-85C2-4A88-937C-56C41F7ECD17Q58867251-1C95D68A-8012-4E62-9698-EAB1B585D344
P2860
Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Structural composition and fun ...... n mass spectrometric analysis.
@ast
Structural composition and fun ...... n mass spectrometric analysis.
@en
type
label
Structural composition and fun ...... n mass spectrometric analysis.
@ast
Structural composition and fun ...... n mass spectrometric analysis.
@en
prefLabel
Structural composition and fun ...... n mass spectrometric analysis.
@ast
Structural composition and fun ...... n mass spectrometric analysis.
@en
P2093
P2860
P356
P1433
P1476
Structural composition and fun ...... n mass spectrometric analysis.
@en
P2093
P2860
P304
P356
10.1042/BJ3160923
P407
P478
316 ( Pt 3)
P577
1996-06-01T00:00:00Z